Advertisement
News
Advertisement

Acton Pharmaceuticals raises $14M funding round

Thu, 09/30/2010 - 10:35am
Mass High Tech: The Journal of New England Technology

Acton Pharmaceuticals Inc., a respiratory therapeutics firm in Marlborough, has raised $14.2 million from an offering of Series A-1 convertible preferred stock, according to a regulatory filing with the U.S. Securities and Exchange Commission.

Although the filing does not identify the two investors in the financing, it does list Sequoia Capital partner Scott Carter, who sits on the Acton Pharmaceuticals board of directors, as a related person in the financing.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading